Research Grants 37 show all


$627.9K
2013

$227.1K
2014

$198.1K
2015

$589.4K
2016

$422.7K
2017

Patents 369show all

  • 179
    A61K - Preparations for medical, dental, or toilet purposes
  • 121
    C12N - Microorganisms or enzymes
  • 57
    C07H - Sugars
  • 39
    C07K - Peptides
  • 25
    Y02A - Technologies for adaptation to climate change
  • 15
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 10
    A01K - Animal husbandry
  • 6
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 3
    C07D - Heterocyclic compounds
  • 2
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms

Clinical Trials 32show all

10Phase 16Phase 26Phase 35N/A3Phase 1/Phase 2

SEC Filings show all


295
8-K

49
10-Q

17
10-K

3
D

1
S-1

Contact Information

Berkeley, CA
United States

SEC Form D Funding Events

DateOfferedSoldType
2010-05-25$181,000$181,000Equity, Option to Acquire, Security to be Acquired, Other
2010-01-07$38,947,480$20,067,480Equity, Debt, Option to Acquire, Security to be Acquired, Other
2008-02-06Unknown Unknown Other (Paper Filing)

Key Executives

  • Dino Dina, M.D.
    Executive Officer, Director
  • Robert L. Coffman, Ph.D.
    Executive Officer
  • Zbigniew Janowicz, Ph.D.
    Executive Officer
  • Michael S. Ostrach
    Executive Officer
  • Jennifer Lew
    Executive Officer
  • Arnold Oronsky, Ph.D.
    Director
  • Nancy L. Buc
    Director
  • Francis R. Cano, Ph.D.
    Director
  • Dennis Carson, M.D.
    Director
  • Denise M. Gilbert, Ph.D.
    Director
  • Mark Kessel
    Director
  • David M. Lawrence, M.D.
    Director
  • Peggy V. Philips
    Director
  • Stanley A. Plotkin, M.D.
    Director